(OMNS, March 19, 2008) Vitamins fight the flu by boosting the body’s own immune response and by accelerating healing. Individuals can be better prepared for an influenza epidemic by learning how to use vitamin supplements to fight off ordinary respiratory infections. The most important vitamins are vitamins C, D, niacin, and thiamine.
Vitamin D
Niacin
Vitamin C
Thiamine (Vitamin B1) [1] http://www.vitamindcouncil.org [2] Cannell JJ et al. Epidemic influenza and vitamin D. Epidemiology and Infection. 2006. Dec;134(6):1129-40. Free access to full text paper at http://www.biochem.wisc.edu/courses/biochem901/secure/materials/readings/09_Cannell.pdf [3] Tavera-Mendoza LE, White JH. Cell defenses and the sunshine vitamin. Scientific American, November 2007, 62-72. [4] Lappe JM et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007 Jun;85(6):1586-91. [5] Abbas S, et al. Serum 25-hydroxyvitamin D and risk of postmenopausal breast cancer - results of a large case-control study. Carcinogenesis. 2008 Jan;29(1):93-9. [6] Freedman DM et al. Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst. 2007. Nov 7;99(21):1594-602. [7] Kaiser JD et al. Micronutrient supplementation increases CD4 count in HIV-infected individuals on highly active antiretroviral therapy: A prospective, double-blinded, placebo-controlled trial. Journal of Acquired Immune Deficiency Syndromes, 2006. 42(5), 523-528. "Micronutrient supplementation can significantly improve CD4 cell count reconstitution in HIV-infected patients. . . " [8] Murray MF. Niacin as a potential AIDS preventive factor. Medical Hypotheses, 1999. 53(5), 375-379. [9] Murray MF, Langan M, MacGregor RR. Increased plasma tryptophan in HIV-infected patients treated with pharmacologic doses of nicotinamide. Nutrition (NY), 2001. 17(7/8), 654-656. [10] Murray MF. Treatment of retrovirus induced derangements with niacin compounds. The Foundation for Innovative Therapies, Inc., USA, 2006. 9 p. US 7012086. [11] Pero RW. A method for increasing tryptophan and nicotinamide levels in vivo, and therapeutic and monitoring methods. Lynpete Trading 6 Pty., Ltd. Trading as Genetic Health Enterprises, S. Afr. PCT Int. Appl. 2008, 73pp. WO 2008008837 A2 20080117 [12] Dube MP et al. Safety and efficacy of extended-release niacin for the treatment of dyslipidaemia in patients with HIV infection: AIDS clinical trials group study A5148. Antiviral Therapy, 2006. 11(8), 1081-1089. "(D)doses up to 2,000 mg daily was safe, well-tolerated and efficacious in HIV-infected subjects. . . " [13] http://www.orthomolecular.org/resources/omns/v04n01.shtml [14] Maynard KI. Natural neuroprotectants after stroke. Science & Medicine, 2002. 8(5), 258-267. [15] Yu, Bi-lian; Zhao, Shui-ping. Anti-inflammatory effect is an important property of niacin on atherosclerosis beyond its lipid-altering effects. Medical Hypotheses, 2007. 69(1), 90-94. [16] Hickey S, Roberts H. Ascorbate: The science of vitamin C. 2004. Lulu Press. ISBN 1-4116-0724-4. Reviewed at http://www.doctoryourself.com/ascorbate.html [17] http://www.orthomolecular.org/resources/omns/v02n01.shtml [18] Ely JT. Ascorbic acid role in containment of the world avian flu pandemic. Experimental Biology and Medicine, 2007. 232(7), 847-851. [19] Cathcart RF. Vitamin C, titrating to bowel tolerance, anascorbemia, and acute induced scurvy. Med Hypotheses. 1981 Nov;7(11):1359-76. Free access to full text paper at http://www.doctoryourself.com/titration.html See also: Cathcart RF. The third face of vitamin C. Journal of Orthomolecular Medicine, 7:4;197-200, 1993. Free access at http://www.orthomoleculartherapy.net/library/jom/1992/pdf/1992-v07n04-p197.pdf or http://www.doctoryourself.com/cathcart_thirdface.html Other Cathcart papers posted at http://www.orthomed.com and http://www.doctoryourself.com/biblio_cathcart.html. [20] Duconge J et al. Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate. PR Health Sciences Journal, 2008. 27:1, March. [21] Shoji, Shozo et al. Thiamine disulfide as a potent inhibitor of human immunodeficiency virus (type-1) production. Biochemical and Biophysical Research Communications, 1994. 205(1), 967-75. "The results suggest that thiamine disulfide may be important for AIDS chemotherapy." [22] Wallace AE, Weeks WB. Thiamine treatment of chronic hepatitis B infection. American Journal of Gastroenterology, 2001. 96(3), 864-868. Editorial Review Board:
Carolyn Dean, M.D., N.D. |
|
|